JPRN-jRCT2063220014进行中(未招募)2 期
Evaluate efficacy and safety of umbilical cord-derived mesenchymal stromal cells (HLC-001) for patient with Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Morio Ikeda0 个研究点目标入组 12 人开始时间: 2022年5月10日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable(—)
- 性别
- All
入选标准
- •1. Patients to meet the IPS criteria by American Thoracic Society
- •2. Patients that the disease worsens after the treatment of more than 1mg/kg/day of corticosteroid (prednisolone equivalent) for 3 days or later, or patients that do not improve the disease after the treatment of more than 1 mg/kg/day of corticosteroid for 5 days
- •3. 16 years or older when informed consent is obtained
排除标准
- •1.Evidence of active infectious pneumonitis
- •2.Respiration failure due to cardiac arrest (Enlargement of heart mental shadows and left ventricular ejection fraction that is less than 45%)
- •3.Patients that received or has received the following medications for concurrent diseases
- •1)Bone Marrow-derived Mesenchymal Stem Cell
- •2)Inhibitor of Bruton tyrosine kinase (BTK)
- •Or patients that clearly need the following medications, therapies after enrollment
- •1)Other systemic immunosuppressant medical treatments
- •2)Increment of corticosteroid except for the use as needed for allergic reaction
- •4.Patients that received therapies for cancer within 3 months of enrollment except for hematopoietic cell transplantation or patients with unstable condition of cancer although therapies were completed more than 3 months before enrollment
- •5.History of acute myocardial infarction within 3 months before enrollment
- •6.Medical History or complication of primary pulmonary hypertension
- •7.The following laboratory test result within 14 days before enrollment except for abnormality to be caused by GVHD
- •1)Serum total bilirubin (TB), 3 times of upper limit of institutional normal range
- •2)Aspartate aminotransferase (AST)and Alanine aminotransferase (ALT), 5 times of upper limit of institutional normal range
- •3)Serum creatinine, 2 times of upper limit of institutional normal range
研究者
相似试验
招募中
3 期
Efficacy of umbilical cord Mesenchymal Stem Cells on patients with neuromuscular disordersIRCT20200426047213N1Tehran Islamic Azad university of Medical Sciences120
招募中
1 期
Safety and efficacy of umbilical cord-derived mesenchymal stem cells treatment for patients with Critical Limb IschemiaCritical Limb Ischemia.Critical Limb IschemiaG173.9IRCT20211021052828N2Rasht University of Medical Sciences5
招募中
1 期
Safety evaluation ofstem cells in multiple sclerosis patientsMultiple sclerosisMultiple sclerosis.IRCT20230806059052N1Bagheiat-allah University of Medical Sciences5
招募中
1 期
Safety and efficacy of injection of Umbilical Cord Blood Serum derived exosomes for skin lesions in patients with chronic psoriasisIRCT20221130056672N4Tehran University of Medical Sciences30
尚未招募
1 期
Safety and Efficacy of Umbilical Cord Blood Serum Derived Extracellular Vesicles versus for Treatment of Androgenic AlopeciaIRCT20221130056672N1Tehran University of Medical Sciences30
